Showing 71 - 80 of 88,001
Prior research shows that technology spillovers across firms increase innovation, productivity, and value. We study how … firms finance their own growth stimulated by technology spillovers from their technological peer firms. We find that greater … technology spillovers lead to higher leverage. This is the result of technology spillovers increasing asset redeployability, as …
Persistent link: https://www.econbiz.de/10012518201
knowledge spillovers are unmeasurable, a 'goodness of fit' measure is constructed using innovation survey data. It turns out … that measures of the uncentered correlation of firm characteristics seem to fit actual knowledge spillovers best. Direct …
Persistent link: https://www.econbiz.de/10013428289
Persistent link: https://www.econbiz.de/10013436252
Persistent link: https://www.econbiz.de/10005678961
We use the French portion of the 2002 Community Innovation Survey to test how spillovers a®ect the likelihood that ¯rms … of the industrial organization literature. We find that a firm which benefits from higher spillovers from her rivals is … more likely to cooperate horizontally in R&D. Moreover, the impact of incoming spillovers on the likelihood of horizontal R …
Persistent link: https://www.econbiz.de/10008789373
the Third Community Innovation Survey from Germany, we focus on the role of spillovers in explaining R&D cooperation. We …This paper analyzes the determinants of R&D co-operation among German manufacturing firms. Using firm level data from … two-step estimation procedure, we find a positive effect of knowledge flows on the probability of R&D co-operation in most …
Persistent link: https://www.econbiz.de/10002821369
Persistent link: https://www.econbiz.de/10013261017
an empirical part that analyses the relationship between R&D Co-operation and knowledge spillovers with regression …The topic of the dissertation is the relationship between knowledge spillovers and firms' likelihood to co-operate on R …
Persistent link: https://www.econbiz.de/10003637930
We provide evidence that risk aversion leads pharmaceutical firms to underinvest in radical andnovel innovation. We do so by introducing a new measure of novelty: a drug candidate is novelif it is molecularly distinct from prior candidates. Using our measure, we show that firms face arisk-reward...
Persistent link: https://www.econbiz.de/10011928975
Several reviews and impact assessment studies have concluded that the Sixth Framework Programme for Research and Technological Development (FP6) succeeded in fostering scientific excellence and attracting the “A Team” in public science. However, these studies typically fail to contrast their...
Persistent link: https://www.econbiz.de/10003969874